FDA Inspection 1299496 — Dr. Souleymane Mboup
The FDA completed an inspection of Dr. Souleymane Mboup on Dec 12, 2025 in Dakar. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 12, 2025
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Dakar (Senegal)
Additional details
Clinical Investigator (CI)